Company Filing History:
Years Active: 2020
Title: Innovations by Rose M Freel in Cognitive Health
Introduction
Rose M Freel is an accomplished inventor based in Mariottsville, MD (US). She has made significant contributions to the field of cognitive health through her innovative research and patent developments. Her work focuses on managing mental and cognitive diseases, particularly those affecting the brain and central nervous system.
Latest Patents
Rose M Freel holds a patent for N-methyl-D-aspartate receptor (NMDAR) potentiators, pharmaceutical compositions, and related uses. This patent discloses tetrahydroisoquinolines, salts, and derivatives that are useful for managing various mental or cognitive conditions. The compounds and compositions described in her patent include prodrugs, esters, or salts, with specific substituents outlined in the documentation.
Career Highlights
Freel is affiliated with Emory University, where she continues her research and development in the pharmaceutical field. Her work has garnered attention for its potential impact on treating cognitive disorders, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Katie L Strong and David Menaldino, who contribute to her research efforts and collaborative projects.
Conclusion
Rose M Freel's innovative work in the realm of cognitive health exemplifies the importance of research in developing effective treatments for mental diseases. Her contributions through patents and collaborations highlight her role as a leading inventor in this critical field.